Invesco Pharmaceuticals ETF
PJP
112 hedge funds and large institutions have $330M invested in Invesco Pharmaceuticals ETF in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 34 reducing their positions, and 14 closing their positions.
50% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 14
6% more funds holding
Funds holding: 106 → 112 (+6)
2.18% more ownership
Funds ownership: 18.78% → 20.97% (+2.2%)
4% more capital invested
Capital invested by funds: $318M → $330M (+$11.7M)
4% less call options, than puts
Call options by funds: $574K | Put options by funds: $595K
9% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 34
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$30.2M |
| 2 |
KSA
Ken Stern & Associates
San Diego,
California
|
+$2.85M |
| 3 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
+$2.06M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.74M |
| 5 |
HCM
Hollencrest Capital Management
Newport Beach,
California
|
+$1.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
FundX Investment Group
San Francisco,
California
|
-$13.7M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.43M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$3.89M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.61M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.13M |
PJP Hedge Fund Activity: Q4 2015 in Review
112 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2015, worth a combined $330M — up 3.7% from $318M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new PJP positions and 14 closed out — a net gain of 7 holders — while 31 added to existing stakes and 34 trimmed.
The largest buyer was LPL Financial, adding an estimated $30.2M. The largest seller was FundX Investment Group, exiting entirely with an estimated $13.7M sold.
- 112 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2015, up from 106 in Q3 2015.
- Funds reported $330M of Invesco Pharmaceuticals ETF stock for Q4 2015, up 3.7% quarter-over-quarter.
- 21 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2015 and 14 closed out, a net change of +7 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2015 was LPL Financial, an estimated $30.2M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2015 was FundX Investment Group, an estimated $13.7M sold.
Based on aggregated 13F filings for Q4 2015.